当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Veronnike Hossa Kowalski1 , Simone Bernardes2 *, Paula Portal Teixeira3 , Kamila Valduga4 , Bruna Espíndola de Araújo5 and Flávia Moraes Silva6
Background: Around half of chronic obstructive pulmonary disease (COPD) patients present nutritional risk when evaluated by Nutritional Risk Screening 2002 (NRS-2002) in the majority of studies. However, the performance of other nutritional screening tools has not been explored in the detail according to the literature. This study aimed to compare the concurrent validity of four nutritional risk screening tools in hospitalized patients with acute exacerbation of COPD.
Methods: A cross-sectional study with patients admitted for exacerbation of COPD. Nutritional risk screening was performed in the first 72 hours of hospitalization by NRS-2002 (reference method), Malnutrition Screening Tool (MST), Malnutrition Universal Screening Tool (MUST), Nutritional Risk in Emergency 2017 (NRE-2017), and Short Nutritional Assessment Questionnaire (SNAQ).
Results: We evaluated 241 patients (68.3 ± 10.2 years, 53.5% women), and the prevalence of nutritional risk ranged from 36.1 to 54.8%. MST, MUST, and SNAQ showed similar accuracy (AUC ROC >0.790), and were significantly higher than the NRE-2017 (AUC=0.742) when compared to the NRS-2002. The MST showed substantial agreement with the NRS-2002, while the other tools demonstrated moderate agreement (Kappa<0.600).
Conclusion: More than 35% of patients hospitalized for exacerbation of COPD presented a nutritional risk. The use of the MST is suggested for nutritional screening in this population due to its accuracy and sensitivity consistent with NRS-2002 screening tool in addition to it being simple, fast, and with easy applicability.